Establishing an Inflammatory Breast Cancer Registry

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

June 30, 2003

Conditions
Inflammatory Breast Cancer
Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

National Cancer Institute (NCI)

NIH

NCT00340158 - Establishing an Inflammatory Breast Cancer Registry | Biotech Hunter | Biotech Hunter